Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Market Dynamics

The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Universite to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.

Key features of the study:

This report provides an in-depth analysis of the global oxytocic pharmaceuticals market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market

Detailed Segmentation:

Global Oxytocic Pharmaceuticals Market, By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
Global Oxytocic Pharmaceuticals Market, By Route of Administration:
- Intramuscular
- Intravenous Injection/Infusion
Global Oxytocic Pharmaceuticals Market, By Source of Origin:
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
Global Oxytocic Pharmaceuticals Market, By End User:
- Hospitals
- Maternity Clinics
Global Oxytocic Pharmaceuticals Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Fresenius Kabi AG *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biofutura SpA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Baxter Healthcare Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Ferring B.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AdvaCare Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- EVER Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3354

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oxytocic Pharmaceuticals Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Synthetic Oxytocin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 - 2030 (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
Maternity Clinics
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)

9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
North America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

10. Competitive Landscape

Company Profiles
- Fresenius Kabi AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Biofutura SpA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Baxter Healthcare Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Ferring B.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
- Novartis AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Abbott
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- AdvaCare Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- EVER Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

11. Section

References
Research Methodology
About us and Sales Contact

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030